Invention Grant
- Patent Title: Use of a particular extract of propolis for combating the side effects of chemotherapy
-
Application No.: US15534950Application Date: 2015-12-11
-
Publication No.: US10532075B2Publication Date: 2020-01-14
- Inventor: Nicolas Cardinault
- Applicant: POLLENERGIE
- Applicant Address: FR Saint-Hilaire-de-Lusignan
- Assignee: POLLENERGIE
- Current Assignee: POLLENERGIE
- Current Assignee Address: FR Saint-Hilaire-de-Lusignan
- Agency: Young & Thompson
- Priority: FR1462244 20141211
- International Application: PCT/FR2015/053453 WO 20151211
- International Announcement: WO2016/092235 WO 20160616
- Main IPC: A61K35/644
- IPC: A61K35/644 ; A23L21/20 ; A23L33/10 ; A61K35/00
Abstract:
The invention relates to the use of a composition comprising at least one extract of propolis, having at least one of the following properties: —an antioxidant value (ORAC) greater than or equal to 500 mmol TE/100 g of dry extract, —a flavones and flavonols content greater than or equal to 5.5% by weight with respect to the total weight of dry material of the extract, —a flavanones and dihydroflavanols content greater than or equal to 5% by weight with respect to the total weight of dry material of the product, in order to prevent and/or limit the side effects of chemotherapy.
Public/Granted literature
- US20170340680A1 USE OF A PARTICULAR EXTRACT OF PROPOLIS FOR COMBATING THE SIDE EFFECTS OF CHEMOTHERAPY Public/Granted day:2017-11-30
Information query
